CLN8 Polyclonal Antibody, AbBy Fluor-488 Conjugated, BF488, Rabbit

Catalog Number: BSS-BS-11715R-BF488
Article Name: CLN8 Polyclonal Antibody, AbBy Fluor-488 Conjugated, BF488, Rabbit
Biozol Catalog Number: BSS-BS-11715R-BF488
Supplier Catalog Number: bs-11715R-BF488
Alternative Catalog Number: BSS-BS-11715R-BF488-100
Manufacturer: Bioss
Host: Rabbit
Category: Antikörper
Application: IF, WB
Species Reactivity: Human, Mouse, Rat
Conjugation: BF488
Alternative Names: Ceroid-lipofuscinosis, neuronal 8 epilepsy, progressive with mental retardation, Cln8, CLN8_HUMAN, EPMR, Protein CLN8, C8orf61
CLN8, a 286 amino acid transmembrane protein, localizes mainly to the endoplasmic reticulum, but also partially to the ER-Golgi intermediate compartment (ERGIC). Mutations in the CLN8 gene cause neuronal ceroid lipofuscinosis 8 and progressive epilepsy with mental retardation (EPMR). Both disorders are forms of neuronal ceroid-lipofuscinose (NCL), a group of progressive neurodegenerative diseases found in children, characterized by failure of psychomotor development, impaired vision, seizures and premature death. The CLN8 protein is one of eight proteins in the CLN family, including CLN1-CLN7, which are associated with NCL.
Clonality: Polyclonal
Concentration: 1ug/ul
NCBI: 2055
UniProt: Q9UBY8
Buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Source: KLH conjugated synthetic peptide derived from human CLN8
Target: CLN8
Application Dilute: WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)